semaglutide .50 mg weight loss .50mg and reduced Pharmacists are bracing themselves for

These equivocal results might be explained by the sample size, the ethnic background, and the lifestyle of studied subjects

People Expand Collapse

To view or add a comment, sign in Pharma Insights by Dr

The specific day does not matter, but the consistency does

Post-marketing surveillance has included reports of: Irritability Mood changes Emotional flattening Anxiety However: These reports are uncommon They do not prove causation They often involve other contributing factors After reviewing these reports, both the FDA and European Medicines Agency concluded there is no clear causal linkbetween GLP-1 medications and serious mood or behavioral disorders, but they recommend clinical monitoring, especially in patients with a psychiatric history